参考文献/References:
[1] KAWASAKI T,KOSAKI F,OKAWA S,et al.A new infantile acute febrile mucocutaneous lymph node syndrome(MLNS)prevailing in Japan[J].Pediatrics,1974,54(3):271-276.
[2] BROGAN P A,BOSE A,BURGNER D,et al.Kawasaki disease:An evidence based approach to diagnosis,treatment,and proposals for future research[J].Arch Dis Child,2002,86(4):286-290
[3] PAONE P,PATRICE D C.Mucus barrier,mucins and gut microbiota:The expected slimy partners[J].Gut,2020,69(12):2232-2243.
[4] CHEN J,YUE Y H,WANG L,et al.Altered gut microbiota correlated with systemic inflammation in children with Kawasaki disease[J].Sci Rep,2020,10(1):14525.
[5] KATHERINE Z S,MELODY Y Z.Neonatal gut microbiome and immunity[J].Curr Opin Microbiol,2020,56:30-37.
[6] 刘进娜,张婵娟,李娜.补中益气汤调控JAK2/STAT3信号通路对气虚发热证大鼠肠道菌群、免疫功能及神经功能的影响[J].陕西中医,2023,44(5):571-574.
[7] LI Y D,ZHENG Q,ZOU L X,et al.Kawasaki disease shock syndrome:Clinical characteristics and possible use of IL-6,IL-10 and IFN-γ as biomarkers for early recognition[J].Pediatr Rheumatol,2019,17(1):1-5.
[8] RIVAS M N,WAKITA D,FRANKLIN M K,et al.Intestinal permeability and IgA provoke immune vasculitis linked to cardiovascular inflammation[J].Immunity,2019,51(3):508-521.
[9] 寇志军,李静,马亨曼,等.川崎病患儿心血管病变易感性与血清N末端B型脑钠肽原、前白蛋白及C-反应蛋白表达水平相关性研究[J].陕西医学杂志,2022,51(6):717-720.
[10] LEE Y,WAKITA D,DAGVADORJ J,et al.IL-1 Signaling is critically required in stromal cells in kawasaki disease vasculitis mouse model:Role of both IL-1α and IL-1β[J].Arterioscler Thromb Vasc Biol,2015,35(12):2605-2616.
[11] QIAN B Y,HUANG H,CHENG M Y,et al.Mechanism of HMGB1-RAGE in Kawasaki disease with coronary artery injury[J].Eur J Med Res,2020,25(1):8-12.
[12] ROUB A A,Akhter N,Rashed F A,et al.TNF-α induces matrix metalloproteinase-9 expression in monocytic cells through ACSL1/JNK/ERK/NF-κB signaling pathways[J].Sci Rep,2023,13(1):14351.
[13] 邓文雯,肖智,姜如.透骨血竭散对类风湿性关节炎模型大鼠炎症因子的影响[J].陕西中医,2023,44(7):868-872.
[14] WANG N N,CHEN Z Y,ZHANG F,et al.Intravenous immunoglobulin therapy restores the quantity and phenotype of circulating dendritic cells and CD4+T cells in children with acute Kawasaki disease[J].Front Immunol,2022,13:802690.
[15] SUZUKI J,ABE K,MATSUI T,et al.Kawasaki disease shock syndrome in Japan and comparison with multisystem inflammatory syndrome in children in european countries[J].Front Pediatr,2021,9:625456.
[16] KANEKO K,AKAGAWA S,AKAGAWA Y,et al.Our evolving understanding of Kawasaki disease pathogenesis:Role of the gut microbiota[J].Front Immunol,2020,11:1616.
[17] GEUJING M B,MCCOY K D,MACPHERSON A J.Metabolites from intestinal microbes shape treg[J].Cell Res,2013,23(12):1339-1340.
[18] RAMANAN D,PRATAMA A,Zhu Y Y,et al.Regulatory T cells in the face of the intestinal microbiota[J].Nat Rev Immunol,2023,23:749-762.
[19] FUKAZAAWA M,JR M F,NANISHI E,et al.Previous antibiotic use and the development of Kawasaki disease:A matched pair case-control study[J].Pediatr Int,2020,62(9):1044-1048.
[20] WANG H,GONG J,WANG W F,et al.Are there any different effects of bifidobacterium,lactobacillus and streptococcus on intestinal sensation,barrier function and intestinal immunity in PI-IBS mouse model?[J].PLoS One,2014,9(3):90153.
[21] ZHOU C,LI L Z,LI T M,et al.SCFA induce autophagy in intestinal epithelial cells and relieve colitis by stabilizing HIF-1α[J].J Mol Med(Berl),2020,98(8):1189-1202.
[22] KIM C H.Control of lymphocyte functions by gut microbiota-derived short-chain fatty acids[J].Cell Mol Immunol,2021,18(5):1161-1171.
[23] WANG F Y,QIAN F Y,ZHANG Q H,et al.The reduced SCFA-producing gut microbes are involved in the inflammatory activation in Kawasaki disease[J].Front Immunol,2023,14:1124118.
[24] HU X L,FAN R,SONG W Z,et al.Landscape of intestinal microbiota in patients with IgA nephropathy,IgA vasculitis and Kawasaki disease[J].Front Cell Infect Microbiol,2022,12:1061629.
[25] KINUMAKI A,SEKIZUKA T,HAMADA H,et al.Characterization of the gut microbiota of Kawasaki disease patients by metagenomic analysis[J].Front Microbiol,2015,6:824.
[26] ESPOSITO S,POLINORI I,RIGANTE D.The gut microbiota-host partnership as a potential driver of Kawasaki syndrome[J].Front Pediatr,2019,7:124.
[27] MAKINO N,NAKAMURA Y,YASHIRO M,et al.Nationwide epidemiologic survey of Kawasaki disease in Japan,2015-2016[J].Pediatr Int,2019,61(4):397-403.
[28] SUN W J,SUN Y H.Recent research on the nuclear factor-kappa B signaling pathway in cardiac injury in children with Kawasaki disease[J].Zhongguo Dang Dai Er Ke Za Zhi,2023,25(3):250-252.
[29] CHENG Z,WENG H,ZHANG J,et al.The relationship between lipoprotein-associated phospholipase-a2 and coronary artery aneurysm in children with Kawasaki disease[J].Front Pediatr,2022,10:854079.
[30] 穆志龙,高颖,卫丽,等.热休克蛋白60、70在川崎病冠状动脉病变中的表达及意义[J].陕西医学杂志,2020,49(9):1117-1120.
[31] ASARAT M,APOSTOLOPOULOS M,VASILJEVIC T,et al.Short-chain fatty acids regulate cytokines and Th17/Treg cells in human peripheral blood mononuclear cells in vitro[J].Immunol Invest,2016,45(3):205-222.
[32] GIORDANI L,QUARANTA M G,MARCHESI A,et al.Increased frequency of immunoglobulin(Ig)A-secreting cells following toll-like receptor(TLR)-9 engagement in patients with Kawasaki disease[J].Clin Exp Immunol,2011,163(3):346-353.
[33] CHEN C Y,HUANG S H,CHIEN K J,et al.Reappraisal of VEGF in the pathogenesis of Kawasaki disease[J].Children(Basel),2022,9(9):1343.
[34] LU L,CAO L,LIU Y,et al.Angiotensin(ang)1-7 inhibits ang Ⅱ-induced atrial fibrosis through regulating the interaction of proto-oncogene tyrosine-protein kinase Src(c-Src)and Src homology region 2 domain-containing phosphatase-1(SHP-1)[J].Bioengineered,2021,12(2):10823-10836.
[35] SANGIORGI E,RIGANTE D.The clinical chameleon of autoinflammatory diseases in children[J].Cells,2022,11(14):2231.
[36] GORELIK M,LEE Y,ABE M,et al.IL-1 receptor antagonist,anakinra,prevents myocardial dysfunction in a mouse model of Kawasaki disease vasculitis and myocarditis[J].Clin Exp Immunol,2019,198(1):101-110.
[37] SALMON M R,HAWKINS R B,DAHL J,et al.Genetic and pharmacological disruption of interleukin-1α leads to augmented murine aortic aneurysm[J].Ann Vasc Surg,2022,85:358-370.
[38] HIRABAYASHI Y,TAKAHAsSHI Y,XU Y,et al.Lack of CD4+CD25+FOXP3+regulatory T cells is associated with resistance to intravenous immunoglobulin therapy in patients with Kawasaki disease[J].Eur J Pediatr,2013,172(6):833-837.
[39] MONIRI N H,FARAH Q.Short-chain free-fatty acid G protein-coupled receptors in colon cancer[J].Biochem Pharmacol,2021,186:114483.
[40] SHI Z,YIN L,LI C,et al.Lipocalin-2-induced proliferative endoplasmic reticulum stress participates in Kawasaki disease-related pulmonary arterial abnormalities[J].Sci China Life Sci,2021,64(6):1000-1012.
[41] KHAN I,Li X A,LAW B,et al.Correlation of gut microbial compositions to the development of Kawasaki disease vasculitis in children[J].Future Microbiol,2020,15:591-600.
[42] RAMAMOORTHY J G,ANANTHARA J A.Pulmonary presentation of atypical Kawasaki disease[J].Indian J Pediatr,2021,88(4):413-414.
[43] KOTLYAROV S.Role of short-chain fatty acids produced by gut microbiota in innate lung immunity and pathogenesis of the heterogeneous course of chronic obstructive pulmonary disease[J].Int J Mol Sci,2022,23(9):4768.
[44] TING A T,BERTRAND M J M.More to life than NF-κB in TNFR1 signaling[J].Trends Immunol,2016,37(8):535-545.
相似文献/References:
[1]原 宁,宁 萍.微生态制剂联合奥美拉唑序贯治疗幽门螺旋杆菌阳性消化性溃疡效果及对患儿丙二醛、转化生长因子β1蛋白水平和肠道菌群的影响[J].陕西医学杂志,2021,50(4):472.[doi:DOI:10.3969/j.issn.1000-7377.2021.04.023]
YUAN Ning,NING Ping.Effect of probiotics combined with omeprazole sequential therapy in treatment of Helicobacter pylori-positive peptic ulcer and its influence on MDA,TGF-β1 protein levels and intestinal flora in children[J].,2021,50(2):472.[doi:DOI:10.3969/j.issn.1000-7377.2021.04.023]
[2]刘应莉,王艳荣,张秋瓒.肠道菌群-过氧化物酶体增殖物激活受体信号通路及其在代谢相关脂肪性肝病发病中的作用研究进展[J].陕西医学杂志,2021,50(9):1166.[doi:DOI:10.3969/j.issn.1000-7377.2021.09.031]
LIU Yingli,WANG Yanrong,ZHANG Qiuzan.Research progress of intestinal flora-PPAR signaling pathway and its role in pathogenesis of MAFLD[J].,2021,50(2):1166.[doi:DOI:10.3969/j.issn.1000-7377.2021.09.031]
[3]孙春晖,乐 原.川崎病合并冠状动脉病变患儿前白蛋白、胱抑素C、血小板四项变化及临床意义[J].陕西医学杂志,2021,50(12):1573.[doi:DOI:10.3969/j.issn.1000-7377.2021.12.027]
SUN Chunhui,LE Yuan.Changes and clinical significance of prealbumin,cystatin C and four parameters of platelet in Kawasaki disease children with coronary arterial lesions[J].,2021,50(2):1573.[doi:DOI:10.3969/j.issn.1000-7377.2021.12.027]
[4]严晓华,王 娜,马 娟,等.阿托伐他汀对小鼠川崎病的治疗作用及机制研究[J].陕西医学杂志,2022,51(6):672.[doi:DOI:10.3969/j.issn.1000-7377.2022.06.007]
YAN Xiaohua,WANG Na,MA Juan,et al.Therapeutic effect and mechanism of atorvastatin on Kawasaki disease mice[J].,2022,51(2):672.[doi:DOI:10.3969/j.issn.1000-7377.2022.06.007]
[5]寇志军,李 静,马亨曼,等.川崎病患儿心血管病变易感性与血清N末端B型脑钠肽原、前白蛋白及C-反应蛋白表达水平相关性研究[J].陕西医学杂志,2022,51(6):717.[doi:DOI:10.3969/j.issn.1000-7377.2022.06.018]
KOU Zhijun,LI Jing,MA Hengman,et al.Correlation between cardiovascular disease susceptibility and serum levels of NT-proBNP,PA and CRP in children with Kawasaki disease[J].,2022,51(2):717.[doi:DOI:10.3969/j.issn.1000-7377.2022.06.018]
[6]石艳红,邵 英.生物钟相关基因CLOCK及褪黑素受体MT1和MT2基因与2型糖尿病患者肠道菌群及炎症因子相关性分析[J].陕西医学杂志,2023,52(3):335.[doi:DOI:10.3969/j.issn.1000-7377.2023.03.021]
SHI Yanhong,SHAO Ying.Correlation of clock-related gene CLOCK,melatonin receptor MT1 and MT2 genes with intestinal microbiota and inflammatory factors in patients with type 2 diabetes mellitus[J].,2023,52(2):335.[doi:DOI:10.3969/j.issn.1000-7377.2023.03.021]
[7]江 娟,李 静,夏 可,等.反复肺炎患儿肠道菌群与免疫功能指标变化及相关性研究[J].陕西医学杂志,2023,52(9):1200.[doi:DOI:10.3969/j.issn.1000-7377.2023.09.019]
JIANG Juan,LI Jing,XIA Ke,et al.Changes of intestinal flora and immune function indexes in children with recurrent pneumonia and their correlation[J].,2023,52(2):1200.[doi:DOI:10.3969/j.issn.1000-7377.2023.09.019]
[8]王一晨,谷慧敏,陈宇华,等.孟德尔随机化在类风湿关节炎相关研究中的应用[J].陕西医学杂志,2024,(11):1562.[doi:DOI:10.3969/j.issn.1000-7377.2024.11.027]
WANG Yichen,GU Huimin,CHEN Yuhua,et al.Application of Mendelian randomization in rheumatoid arthritis-related research[J].,2024,(2):1562.[doi:DOI:10.3969/j.issn.1000-7377.2024.11.027]
[9]杨 敏,刘 鑫.血清可溶性肿瘤坏死因子受体Ⅱ/Ⅰ比值、白细胞介素-17联合心电图诊断川崎病患儿急性期冠状动脉损伤的价值[J].陕西医学杂志,2025,54(3):338.[doi:DOI:10.3969/j.issn.1000-7377.2025.03.010]
YANG Min,LIU Xin.Value of serum sTNFR Ⅱ/Ⅰ,IL-17 combined with ECG in diagnosis of coronary artery injury in children with Kawasaki disease in acute phase[J].,2025,54(2):338.[doi:DOI:10.3969/j.issn.1000-7377.2025.03.010]
[10]冯千伟,王晓青,焦丽华,等.川崎病患儿血清血管生成素样蛋白8、生长分化因子-15水平与并发冠状动脉病变关系研究[J].陕西医学杂志,2025,54(3):364.[doi:DOI:10.3969/j.issn.1000-7377.2025.03.015]
FENG Qianwei,WANG Xiaoqing,JIAO Lihua,et al.Relationship between serum ANGPTL8,GDF-15 levels with concurrent coronary artery disease in children with Kawasaki disease[J].,2025,54(2):364.[doi:DOI:10.3969/j.issn.1000-7377.2025.03.015]